This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ventas, Inc. is a healthcare real estate investment trust (REIT) that is primarily engaged in acquisition and ownership of senior housing, R&I and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. Ventas offers MOB management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems throughout the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc. It also makes secured and non-mortgage loans and other investments relating to senior housing and healthcare properties or operators.
Duke Realty (DRE) Q3 FFO Beats Estimates, Revenues Miss
by Zacks Equity Research
Duke Realty Corporation (DRE) witnessed same-property net operating income growth on the back of robust rental growth in Q3. Nonetheless, total occupancy declined sequentially.
MAA Q3 FFO Tops Estimates, Revenues Miss, Outlook Raised
by Zacks Equity Research
Mid-America Apartment Communities (MAA) reported robust operating results in Q3 on the back of growth in rental revenues. The residential REIT exited the quarter with higher liquidity.
Can Macerich (MAC) Maintain its Beat Streak in Q3 Earnings?
by Zacks Equity Research
Rising popularity of e-commerce and increasing number of retailers joining the dot-com bandwagon will likely put pressure on the top-line figure of The Macerich Company (MAC) in Q3.
What's in the Offing for Vornado (VNO) This Earnings Season?
by Zacks Equity Research
Vornado's (VNO) business streamlining measures and spin-offs are expected to dent its Q3 performance. Let's see if this REIT is still poised for a beat despite the headwinds.
PS Business Parks (PSB) Q3 FFO and Revenues Top Estimates
by Zacks Equity Research
PS Business Parks' (PSB) Q3 results highlight impressive growth in rental revenues and net operating income (NOI). Also, the company exited the quarter with higher liquidity.
Highwoods Properties' (HIW) Q3 FFO Beats, Outlook Improved
by Zacks Equity Research
Highwood Properties' (HIW) Q3 results mirror robust growth in revenues and healthy demand for office space. However, the company's liquidity weakened at the end of the quarter.
Liberty (LPT) Q3 FFO & Revenues Top, View Raised, Stock Up
by Zacks Equity Research
Liberty Property's (LPT) Q3 results reflect rent escalation on renewal and replacement leases signed during the quarter in the industrial portfolio. Occupancy also moved up from the prior quarter.
What's in the Offing for Ventas (VTR) This Earnings Season?
by Zacks Equity Research
Ventas (VTR) could benefit from favorable demographics and portfolio-diversification initiatives in Q3.
Ventas (VTR) to Gain from Life Science Assets and SNF Sale
by Zacks Equity Research
Ventas' (VTR) life-science real estate investments and lowering of skilled nursing facilities' exposure augur well for growth, but rising supply of senior housing assets remains a concern.
Top Research Reports for Disney, Kraft Heinz & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), Kraft Heinz (KHC) and CVS Health (CVS).
Ventas Sells 22 Kindred-Operated SNFs Out of 36 in Phase I
by Zacks Equity Research
Ventas (VTR) will be able to bring down its NOI from skilled nursing facilities to just 1% of its aggregate NOI, following the anticipated sale of the total 36 Kindred operated facilities.
Ventas' (VTR) Life Science Asset Investments to Stoke Growth
by Zacks Equity Research
Ventas (VTR) is making investment for future prospects through selective development and redevelopment. This would include new ground-up medical office and life science developments.
Top Stock Reports for United Technologies, NVIDIA & Raytheon
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including United Technologies (UTX), NVIDIA (NVDA), and Raytheon (RTN).
Ventas (VTR) Beats Q2 FFO Estimates, Reiterates 2017 View
by Zacks Equity Research
Ventas' (VTR) solid Q2 results were supported by growth in revenues. The company also reiterated its 2017 normalized FFO per share outlook.
Ventas (VTR) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Ventas (VTR) came up with a better-than expected performance in Q2. Results reflect improved property performance and accretive investments.
REIT Stocks' Q2 Earnings Queued for Jul 28: HCN, VTR & IRM
by Zacks Equity Research
The sentiment in Q2 has been mixed so far, with results from some of the top notch REIT stocks either matching estimates or beating, and a few others falling shy of expectations.
PS Business Parks (PSB) Q2 FFO Tops Estimates, Revenues Miss
by Zacks Equity Research
Higher net operating income and reduced interest expenses drove PS Business Parks' (PSB) Q2 results.
Liberty (LPT) Q2 FFO and Revenues Beat, Fall Y/Y, Stock Down
by Zacks Equity Research
Liberty Property's Q2 results reflect rent escalation on renewal and replacement leases signed during the quarter in the industrial portfolio. However, occupancy fell from the prior quarter.
Ventas (VTR) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Ventas is likely to benefit from diversified portfolio and strategic investments. But, supply increase can dampen performance in Q2. Let's see if the stock is poised for a beat.
Ventas (VTR) Reiterates Sale of 36 Kindred Operated SNFs
by Zacks Equity Research
Ventas Inc. (VTR) has reaffirmed the expected sale of 36 skilled nursing facilities (SNFs), for $700 million, which are currently being operated by Kindred Healthcare.
Ventas to Gain from Life Science Real Estate Investments
by Zacks Equity Research
University-based life science real estate is a new zone of investment that has caught attention and Ventas Inc. (VTR) has, by now, committed roughly $2 billion to this segment.
Why Is Ventas (VTR) Up 3.8% Since the Last Earnings Report?
by Zacks Equity Research
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ventas' (VTR) FFO and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Ventas, Inc. (VTR) reported first-quarter 2017 normalized funds from operations of $1.03 per share.
Ventas' (VTR) Q1 FFO & Revenues Beat Estimates
by Zacks Equity Research
Ventas came out with first-quarter 2017 normalized funds from operations (FFO) per share of $1.03.
Duke Realty (DRE) Surpasses FFO & Revenue Estimates in Q1
by Zacks Equity Research
Duke Realty Corporation's (DRE) first-quarter 2017 core funds from operations ("FFO") per share of 32 cents surpassed the Zacks Consensus Estimate of 29 cents and came in 4 cents ahead of the year-ago figure.